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We show here that the element which was previously 
characterized as a retinoid X receptor (RXR)-specific 
response element (RXRE) in the rat cellular retinol- 
binding protein I1 (CRBPII) gene is not conserved in 
the mouse gene. However, two conserved cis-acting 
elements (RE2 and RE3) located in the promoter region 
of the mouse and rat CRBPII genes mediate trans- 
activation by retinoic acid receptors (RARs) and RXRs 
in transfected Cos-1, CV-1, and HeLa cells, The ele- 
ment RE3 which is the major retinoic acid (RA) re- 
sponse element also binds the transcription factors 
HNF-4 and ARP-1. HNF-4 constitutively  activates the 
mouse CRBPII promoter, whereas ARP-1 represses 
the activation mediated by RARs,  RXRs,  and HNF-4. 
In contrast, RA has no effect on the activity of the 
mouse  CRBPII  promoter in the human colon carcinoma 
cell  line CaCo-2 which constitutively  expresses RARa, 
RARy, RXRa, HNF-4, and ARP-1, under conditions 
where the activity of the RARBP gene promoter is 
readily induced by RA. Our results suggest that the 
CRBPII gene may not be RA-inducible in tissues ex- 
pressing HNF-4 and ARP-I, and that the RA induci- 
bility of the CRBPII gene promoter observed in trans- 
fection experiments reflects the promiscuous binding 
of RARs/RXRs to HNF-4 and ARP-1 response ele- 
ments. 
Retinoids, which are  structurally  related to retinol (vitamin 
A) and  its acidic form retinoic acid (RA),’ appear to play a 
major role in embryogenesis, cell growth and differentiation, 
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and homeostasis (for reviews see Refs. 1-10). The pleiotropic 
action of retinoids is mediated through binding to multiple 
receptors which belong to  the family of steroid-thyroid  hor- 
mone receptors, and act as ligand-inducible trans-regulators 
that modulate the transcription of target genes by interacting 
with cis-acting DNA RA response elements (RAREs). The 
three types of retinoic acid receptors  (RARs), RARcu, /3, and 
7 ,  can bind and respond to  all-trans  (T-RA)  and 9-cis (9C- 
RA) retinoic acids, whereas the retinoid  X receptors (RXRs), 
RXRa, @, and y, can bind and respond to 9C-RA, but not  to 
T-RA (11-14).  RAR and  RXR bind cooperatively as  hetero- 
dimers to RAREs in uitro, more strongly than  the respective 
homodimers (15-20). These heterodimers have been shown 
to mediate enhanced T-RA and 9C-RA retinoid-dependent 
transcription from RARE-containing target promoters (see 
above, Refs. 14 and 21). Natural RAREs appear to consist of 
a  direct  repeat (DR) of two core motifs (5‘-RG(G/T)TCA or 
a closely related sequence) separated by a spacer of variable 
length of either  5  bp (DR5; RARa2 gene (22), RARP2 gene 
(23, 24), ADH3 gene (25), complement factors  H gene (26), 
RARr2 gene (27)), 4 bp (DR4; laminin B1 gene (28)), 2 bp 
(DR2; CRBPI gene (29),  CRABPII gene (21)) or 1 bp (DR1; 
CRABPII gene (21)) (for  a review,  see  Ref. 14). 
Two classes of cellular retinoid-binding  proteins, while not 
directly implicated in transduction of the retinoid signal, 
probably play important roles in retinoid metabolism and 
homeostasis. The cellular RA-binding proteins, CRABPI and 
11, bind T-RA,  but  not 9C-RA, with high and slightly different 
affinities (see Refs. 13 and 30-32 and references therein). 
Although the precise function of these two proteins is un- 
known, they may be involved in the control of the concentra- 
tion of free RA within a given cell (see Refs. 7 and 33 and 
references therein)  and  in intracellular RA metabolism (see 
Refs. 34 and 35 and references therein). The two cellular 
retinol-binding  proteins, CRBPI  and 11, may play a role in 
the storage and metabolism of retinol. CRBPI which is ex- 
pressed in many tissues has been suggested to regulate the 
formation of retinyl esters, the major form of storage of 
retinol, whereas CRBPII, which is expressed mostly in  pre- 
natal liver, intestine, and lung just prior to  birth,  and  in adult 
intestine, may be involved in the intracellular transport of 
retinol  during intestinal absorption (32, 36-38) (see Refs.  39 
and 40 for reviews). 
Interestingly, the expression of the CRABPII and  CRBPI 
genes has been previously shown to be inducible by RA, 
ase; T-RA, all-trans-retinoic acid; g-cis-RA, 9-cis-retinoic acid PCR, 
polymerase chain reaction; DR, direct repeat; ER, estrogen receptor; 
RE, response element; bp, base pair; kb, kilobase pair. 
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therefore  providing  possible  feed-back  mechanisms to regulate 
the levels of RA (21, 29, 31, 41-43). The goal  of the present 
study  was to investigate whether the expression  of the mouse 
CRBPII  (mCRBPII) gene  could also be  controlled by 
RA, which was suggested to us by the presence of several 
RG(G/T)TCA related motifs in the proximal region of the 
rat CRBPII gene promoter (44). We show here that two 
putative RAREs (RE2 and RE3) are conserved  in the rat  and 
mouse CRBPII gene 5’-flanking regions. These two  putative 
proximal RAREs (RE2 and RE3) which  correspond to a DR2 
and a DR1 element, respectively, are required for maximal 
RA induction of the CRBPII promoter  upon  cotransfection 
with RAR and RXR expression vectors, whereas the more 
distal  response element (RE1) which was previously  charac- 
terized as a RXRE in the rat CRBPII (rCRBPI1) 5’-flanking 
sequence (45) is not conserved in the mouse gene. Interest- 
ingly, the RE3  DR1 element, which is responsible for most  of 
the RA inducibility in transfection experiments, binds effi- 
ciently to two  other  members  of the nuclear  receptor  super- 
family, HNF-4 and ARP-1, both of which are expressed in 
liver  and intestinal cells. We  show that HNF-4 constitutively 
activates the mCRBPII promoter, whereas ARP-1 competi- 
tively represses its activation by RAR, RXR, and HNF-4. 
Taken  together our results  strongly  suggest that the expres- 
sion of the CRBPII gene  in intestinal cells may  not be 
controlled by RA, and that the activation of the CRBPII 
promoter  by  overexpressed RAR and RXR reflects the pro- 
miscuous binding of RA receptors to HNF-4 response ele- 
ments. 
MATERIALS AND  METHODS 
Isolation of Mouse CRBPII cDNA and 5”Flanking Genomic  DNA 
Clones and Mapping of the Transcription Starting Site by Primer 
Extension-mCRBPII cDNA was cloned by two PCR steps with 
reverse transcribed adult mouse intestinal poly(A) RNA. In  the first 
step, degenerate oligonucleotides corresponding to amino acids 7-12 
and a  3”untranslated region antisense oligonucleotide 5’- 
GGCTTCCCCTGGGCCCATCA (nucleotides 459-478)  of the rat 
CRBPII cDNA (46) were used to amplify the cDNA and subsequently 
cloned into Bluescript SK+. To obtain the sequence coding for the 
remaining N-terminal  amino acids and  5’-UTR,  an antisense oligo- 
nucleotide corresponding to amino acids 105-121 (Fig. 1A) was used 
to reverse transcribe  intestinal mRNA, and  the resulting cDNA  was 
dG-tailed. Anchored PCR was performed with another antisense 
nested primer corresponding to amino acids 87-103 (Fig. U) as 
described elsewhere (47),  and the PCR product was subcloned into 
Bluescript SK+. The unique EugI site a t  position 294  of the cDNA 
(Fig. L4) was used to generate a full-length cDNA which was se- 
quenced on both strands by dideoxy chain  termination procedure. 
A mouse genomic XEMBL3 library (a gift from L. Stubbs) was 
screened with the 32P-5’-end-labeled oligonucleotide (0x42) corre- 
sponding to nucleotides 82-130  of the mCRBPII cDNA (overlined in 
Fig. 1A). Four recombinant XEMBL3 phages containing -12 kb 
inserts were isolated and a 4.3-kb HindIII fragment was subcloned 
into the HindIII site of Bluescript SK+ to derive the plasmid 
CRBPII/SK+l.  The -2.3-kb BspHI fragment of CRBPII/SK+l was 
treated with Klenow and cloned into the SmuI site of SK+  to yield 
the plasmid CRBPII/SK+2. Note that one of the BspHI restriction 
site overlaps the initiation codon of the mCRBPII cDNA (Fig. 1A). 
using the synthetic oligonucleotide 5’-CATTACTCTCCATTTCC- 
The transcriptional starting  site was mapped by primer extension 
CAGG-3’ complementary to nucleotides +80 to  +lo0 in the genomic 
sequence (Fig. 1B). The 32P-5’-end-labeled oligonucleotide was an- 
nealed at  30 “C with 3 pg  of poly(A) RNA from mouse intestine and 
extended using avian myeloblastosis virus reverse transcriptase as 
describedpreviously (48). Primer extension products, along with DNA 
sequencing reactions of CRBPII/SK+l using the above oligonucleo- 
tide as a primer, were electrophoresed on 6% urea-polyacrylamide 
gels and autoradiographed (Fig. IC). 
CRBPII/SK+2 was digested with BarnHI and XhoI and  the fragment 
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containing the mCRBPII promoter sequence was ligated into  BamHI- 
XhoI sites of  pBLCAT3’ (49) yielding the plasmid mCRBPII/CATl. 
mCRBPII/CAT2 was generated by digesting mCRBPII/CATl with 
SphI and religation. For  creating  mCRBPII/CAT3 and  mCRBPfI/ 
CAT4 deletion mutants, nested deletions were done in  CRBPII/SK+2 
by first digesting with Sac11 and BamHI and subsequently with 
exonuclease 111 and mung bean nuclease as described previously (48). 
mCRBPII promoter fragments were prepared from the clones ob- 
tained with the above material which  was sequentially treated with 
Sad, S1 nuclease, and XhoI, before ligation into  the Klenow-treated 
BamHI  site and  the XhoI site of pBLCAT3+. Deletion end points in 
mCRBPII/CAT3 and mCRBPII/CAT4 were identified by sequenc- 
ing. mCRBPII/CAT5 and mCRBPII/CATlO were generated by li- 
gating PCR-amplified fragments of CRBPII/SK+2 into BamHI-XhoI 
sites of  pBLCAT3’. The oligonucleotide 5”CCGGATCCTGT- 
GAACTGAGACAAAATGA-3’ plus M13 universal primer and the 
oligonucleotide 5”GGGATCCCTGATGGAATGTTCTGTGTG plus 
mCRBPII fragments present in mCRBPII/CAT5 and mCRBPII/ 
M13 universal primer were used as primers for amplification of the 
CAT10, respectively. 
The reporter constructs mCRBPII/tk-CATG, mCRBPII/tk-CAT2, 
and mCRBPII/tk-CAT5 were generated by ligating various lengths 
of mCRBPI1 promoter fragments into the SphI-BarnHI sites of 
pBLCAT8+ (29). Promoter fragments were obtained by PCR ampli- 
fication of CRBPII/SK+2 (for tk-CAT6 and CATS) or mCRBPII/ 
CAT4 (for  tk-CAT5) using the following primers: 5”GGGGATCCG- 
GACCAGGTATATAAAGATA-3‘ and 5”TTCTTGCATGCAAG- 
GCCTGTGAGG-3’ for mCRBPII/tk-CAT6 5”AAGGATCCGGT- 
CTGCAAGGCTCATG-3’ and TTCTTGCATGCAAGGCCTGTG- 
AGG-3’ for mCRBPII/tk-CATO; 5”GGGGATCCGGACCAGGTA- 
TATAAAGATA-3’  and 5’-GCTTGCATGCCTGCAGGTCG-3’ 
(corresponding to pBLCAT3’ sequence) for mCRBPII/tk-CAT5. 
The point mutants mCRBPII/CAT3 mutl  to mut4 were generated 
by two-step PCR amplification as described by Ho et al. (50) using 
mCRBPII/CAT3 as template. The same procedure was  used to gen- 
erate mCRBPII/CAT3 mut5, mut6, mut7, and  mut8 by using 
mCRBPII/CAT3 mutl, mut2, mut3, and mut7 as templates, respec- 
tively. 
Expression vectors for mRARal, mRARP2, mRARy1, mRXRa, 
mRXRp, and mRXRy have been described previously (17, 51). The 
HNF-4 expression vector was constructed by cloning HNF-4 cDNA 
(a kind gift from W. Zhong and J. Darnell) into the EcoRI site of 
pSG5 (52). The cDNA for ARP-1 was recloned from CaCo-2 cell 
mRNA by PCR amplification using previously published sequences 
as primers ((53); 5’-GGGAATTCCGGAAGTCCGGACGCAGCCC- 
CCATAGATATGG-3’ (nucleotides 316-346) and 5”GGAGATCTC- 
CTTTTCTTTCTCTGTTTCACTCCCCCT-3’  
(complementary strand, nucleotides 1599-1630)). The cDNA  was 
cloned into  the EcoRI-BglII sites of pSGS; our cloned isoform  does 
not  contain  amino acids 5-48 of the published cDNA. The human 
estrogen receptor (ER) DNA fragment coding for amino acids 553- 
595 (54) was fused in-frame to  the 3’-end of the  HNF-4 or ARP-1 
coding sequences to obtain antigen-tagged proteins. 
Cell Transfection and CAT Assays-Cos-1 and CV-1 cells were 
cultured in Dulbecco’s  medium containing 5% delipidated fetal calf 
serum. F9, P19, and HepG2 cells were maintained in Dulbecco’s 
medium containing 10% charcoal-treated serum. CaCo-2 cells were 
maintained in Dulbecco’s medium with 20% charcoal-treated me- 
dium. Cells were transfected 12-16 h after plating by a calcium 
phosphate procedure as described previously (55) with 5 pg  of reporter 
plasmids, 0.5  pg  of expression vectors unless stated otherwise in the 
figure legends, and 2 pg of the @-galactosidase expression vector 
pCHllO (Pharmacia LKB Biotechnology Inc.) which  was  used as an 
internal control for transfection efficiency. The total  amount of  DNA 
in each transfection was standardized to 20 pg using carrier DNA 
(Bluescript). In all transfections, the amount of expression vector 
was kept constant by substituting with pSG5. The medium was 
changed after 15-20 h, and the appropriate ligands dissolved in 
ethanol were added. After an additional 20-24 h, the cells were 
harvested, and cell extracts were prepared as described previously 
(56). The CaCo-2 cell extracts were heated at 65 “C for 5 min  before 
CAT assays. The CAT activity was quantified by liquid scintillation 
counting. 
Gel Retardation Assay-Preparation and incubation of either in 
vitro transcribed-translated receptors and whole cell extracts with 
32P-5’-labeled oligonucleotide probes (in the presence of 100 mM 
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KCU, and gel retardations were as described previously (17, 57). only amino acid differences correspond to valine and aspara- 
Antibody preparations used in “supershift” assays were as described gine in r ~ ~ ~ p ~ ~  instead of threonine and histidine at 
elsewhere (17, 28). The sequences of the oligonucleotide probes are m~~~~~~ positions 44 and 82, respectively. 
listed in Table 11. Assuming that the rat and mouse CRBPII genes have 
similar intronlexon organization and  that sequences up to 
nucleotide 130 of the cDNA represent the  first exon (44), we 
Comparison of Mouse and  Rat  CRBPII cDNA, Tramcription employed an oligonucleotide corresponding to nucleotides 82- 
Starting Sites, and 5”Fhnking Genomic Sequences-The 130 of the cDNA (0x42, overlined in Fig. lA) to probe a 
amino acid-coding sequence of the mouse CRBPII XEMBL3 mouse  genomic library. Four clones containing 
(mCRBPI1) cDNA (see “Materials and Methods”) and de- DNA inserts (-12 kb) with similar restriction enzyme site 
duced amino acid sequence (134 residues, molecular mass = patterns were obtained. Further analysis of a 4.3-kb  Hind111 
18,005 daltons; see Fig. LA) are 94.8 and 98.5%  homologous fragment, which hybridized with the OX42 probe in  Southern 
to their rat (rCRBPI1) counterparts, respectively (44). The blots, identified a  BspHI  fragment which extended -2.3 kb in 
RESULTS 
A 
47 AGGCCACCATC ACG AAG GAC CAA AAT GGA ACC TGG GAA ATG 
1 M T K D Q N G T W E M  
1 CTACAGCCTGTTCCTTCACAGTCACTGAACGTCCATATCMCCAG 
91 GAG AGT AAT GAG AAC TTT GAA GGC TAC ATG AAG GCC CTA GAT 
~ ~ E S N E N F E G Y M K A L D  
133 ATT GAT TTT GCC ACC CGC AAG ATC GCA GTG CGT CTG ACT CAG 
2 6 I D F A T R K I A V R L T Q  
175 ACG AAG ATC ATC ACT CAA  GAC GGT GAT AAC TTC AAG ACG AAA 
4 0 T K I I I Q D G D N F K T K  
217 ACC AAC AGC ACG TTC CGC AAC TAC GAC CTG GAT TTC ACC GTC 
5 4 T N S T F R N G D L D F T V  
259 GGG GTG GAG TTT GAC GAA CAC ACA AAG GGC CTG GAC GGC CGA 
6 8 G V E F D E H T K G L D G R  
301 CAT GTC AAG ACC CTG GTC ACC TGG GAA GGC AAC ACC CTC GTG 
8 2 X V K T L V T   W E G N T L V  
343 TGT GTG CAG AAA GGG GAG AAG GAG AAC CGT GGC TGG AAG CAG 
9 6 C V Q K G E K E N R G W K Q  
385 TGG GTG GAG GGA GAC AAG CTG TAC CTG GAG CTG ACC TGC GGC 
1 1 0 W V E G D K L Y L E   L T C G  
427 GAC CAG GTG TGC CGA CAA GTG TTC AAA AAG A A G m  TGGGCCC 
1 2 4 D Q V C R Q V F K K K -  
470 AGGGGAAGCC 
C I 
3”ACGAGGGATGTGG.S 
6 
INTEST. RNA 
tRNA 
B 
-997 AGCTAAAGACAGGGCCCTTTCTTTGTTTCACTGCTTATTTTGACCTGCGTGCAACTTCAC 
-937 TAAGCAATGGGCCCTCAAGAGACTAGGTTTCCTGTCTGTTTCCCCTTCTTGTCTTATATC 
-877 AGCACCAACAGCTCTTTCTCTCTATGCCCATTTACACCCAGGCTTCCTGCTCACCACAAT 
-817 TAATAGCCCTTCTTATCTTCAGCCCCACCCCACCAGGCCAGCTTTCCTTATATTCTTGCA 
-757 TGCAAGGCCTGTGAGGTTTGGGGGGACTGTTTTAAAGTGCTTAAATCTGAATGTGGAAGG 
-697 CAAGTGATGAATCCCCAAAGGTCCTTTCTGTCCCATTCTGCTGTCA~G~TC~GTTC 
5 6 
-637 TTTTCCAGGTTCTGTCTTTTACAAGTCACCATTGGGCTTGATCATTTAACTTCCATGAGC 
-RE1- 
-577 CTTGCAGACCTGGAGAGAGAGAGAGAGAGAGAGGGGGGGGGGGAGAGAGAGAGAGAGAGA 
-517 GAGAGAGAGAGAGAGAGAGAGAGA~GAGTC~GAGGTGGGGAGGGCTGTTAAATATAAC 
-457 CCACAGAGCTTTTGTGAACTGAGAC-TGAAGTTCAAGTGTGGCTTGGCACAAGAACA 
-397 GTTCCTCAGATGTPSrAAACCCACCATGAGCTTCACTGGCCAAATCAATGCTCCTTATGTG 
-377 ATAGGCAGGCCTGGCTCCGGTGTCCTGCAGAACGTGTGGGACAAATACTGAGTGTTTGTT 
-277 TTCCTTAGGAACTGATGGAATGTTCTGTGTGAGGCCAGGACTCTGTGGGAGGCCAGTGAG 
-217 CCTAAAATGAGCTGCTCCAAGGCAGTGTGTCATG~AGATCAC~GGGACACGCAGACCTGG n_ 
-157 
- 97 
- 37 
D 
+ 24 ACTGAACGTCCATATCAAACCAGAGGCCACCAT~CGAAGGACC~TGGAACCTG 
+ 84 GGAAATGGAGAGTAATGAGAGI\ACTTTGAAGGCTACATGAAGGCCCTAG 
RE1 
mCRBPII -668 GTCCCATTCTGCTGTCAC------------- 
KCRBPII -649 GTCCCACTCTGCTGTCACAGGTCACAGGTCA 
* .*”)”” 
I 
-633 CCAGGTTCTGTCTTTTACAA -614 rRXRE 
-600 CCTGTCTCTGTCTTTTACAA -580 * ** RE2 , i 
* * * 
RE3 
+1 
FIG. 1. A ,  sequence of the mouse CRBPII cDNA and predicted amino acid sequence (see  “Materials and Methods”). The ouerlined  sequence 
represents the sequence of the oligonucleotide used for screening the genomic library. The two amino acids that  are different from those of 
rat CRBPII are underlined. Initiation and stop codons are boxed. B,  sequence of the mouse CRBPII gene 5’-flanking region. Nucleotides are 
numbered such that +1 corresponds to the longest reverse transcribed  product  (see text  and panel C ) .  Sequences corresponding to 5’-RG(G/ 
T)TCA or related motifs (5’-TGA(A/C)CY on the  other  strand)  are bored and numbered 1-6. Repeated motifs that appear in pairs are labeled 
as REI, 2, and 3. The TATA box, the initiation codon, and  the AP-1 binding site (5”TGAGTCA-3’) are also boxed. Stretches of repeating 
AG dinucleotides are ouerlined. C, mapping of the  CRBPII  starting site by primer  extension analysis. Products of primer  extension using 
either 3 pg of poly(A) RNA from mouse intestine (lane 5) or tRNA (lane 6 ) ,  were resolved on a 6% urea-polyacrylamide gel and 
autoradiographed. Lanes G,  A ,  T, and C contained sequencing reaction products of CRBPII/SK+l with the primer used for primer extension. 
Arrows represent major primer extension products. The sequence shown corresponds to  the non-coding strand. D, alignment of the 5’- 
flanking sequences of mouse and  rat  CRBPII genes. Non-conserved bases are indicated by asterisks. Arrows indicate the repeated motifs of 
the  rat CRBPII promoter which have been described as  an  rRXRE (45). Other symbols are  as in B. 
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the 5‘ direction from the initiator codon. Approximately 1 kb 
of this fragment was sequenced (Fig. 1B);  as expected its 3’ 
extremity overlapped with the 5’ end of the cDNA. To map 
the mCRBPII starting site, primer extension analysis was 
performed using an oligonucleotide corresponding to nucleo- 
tides +80 to  +lo0  in  the cDNA and poly(A) RNA from mouse 
intestine (Fig. 1C). As is the case for rCRBPII (44), several 
starting sites were found (Fig. 1, B and C). The 5’-most 
nucleotide of the longest reverse transcript, which also cor- 
responded to the 5‘ end of the cDNA, was considered as 
position +1 of the mCRBPI1 gene. 
A comparison between the mCRBPII  and  rCRBPII proxi- 
mal promoter sequences reveals a high degree of similarity 
(Fig. 1D). Identical sequences that may  be functionally im- 
portant include the TATA box, and sequences corresponding 
to 5’-RG(G/T)TCA motifs (5’-TGA(A/C)CY, on the  other 
strand) which have been characterized in a number of natural 
and synthetic response elements for nuclear receptors (see 
Introduction and below) (elements RE1, RE2, and RE3, mo- 
tifs 1-6, in Fig. ID). On the  other hand, the CAAT boxlike 
sequence present at position -93 to -96 in the rCRBPII 
promoter (44),  and the AP-1 binding site (5”TGAGTCA-3’) 
found at position -486 to -492 in  the mCRBPII promoter 
(Fig. 1B) are not conserved between the two species. In 
addition, the mCRBPII AG repeat (ouerlined in Fig. 1B) is 
replaced by a TG repeat in rCRBPII. Interestingly, the se- 
quence 5’-AGGTCACAGGTCA-3‘ located at position -631 
to -619 in the rCRBPII promoter, which together with the 
RE1 element was previously characterized as corresponding 
to a specific RXR response element (RXRE, see Ref. 45), is 
not  present in the mCRBPII  5“flanking region (Fig. ID). 
Characterization of Retinoic Acid Response Elements in the 
5’-Flunking Region of the Mouse CRBPII Promoter-To in- 
vestigate whether response elements  (RES) for retinoic acid 
receptors may possibly be present  in the mCRBPII  5”flank- 
ing region, the reporter plasmid mCRBPII/CATl, which con- 
tains -2.3 kb of 5”flanking sequences inserted in pBLCAT3’ 
(see “Materials  and  Methods”), was transfected  into various 
cell types together with vectors expressing RARa1 (also called 
RARa  hereafter) or RXRa (see Table  I for a summary of the 
results). Upon cotransfection with the parental expression 
Iter by Nuclear Receptors 893 
vector (pSG5), no significant constitutive nor T-RA- or 9C- 
RA-inducible mCRBPII/CATl expression was observed in 
Cos-1 cells (Fig. 2A, lanes 22-24; Table I). Similar results 
were obtained in HeLa cells, CV-1 cells, and F9 and P19 
embryonal carcinoma (EC) cells (Table I, and  data  not 
shown). A weak constitutive activity (-2-3-fold  above 
pBLCAT3+), which  was not significantly increased by addi- 
tion of T-RA or 9C-RA  was observed in human colon carci- 
noma CaCo-2 and hepatoma HepG2 cells (Table I, and  data 
not shown). Under similar conditions, the expression of a 
reporter gene containing the RA-inducible RARP2 promoter 
(mRARP2/CAT, see Ref. 29)  was  effectively stimulated in the 
same cells by endogenous RARs in the presence of either T- 
RA or 9C-RA (Fig. 2 A ,  lanes 13; Table I, and data not 
shown). 
Cotransfection of mRARa1, mRARP2, mRXRa,  and 
mRXRy,  but  not of mRARyl  and mRXRP expression vec- 
tors, resulted in RA-inducible expression of mCRBPII/CATl 
in Cos-1 cells (Fig. 2 A ,  lanes 25-42; the low activity seen in 
lane 33 was not reproducibly observed). In HeLa cells, induc- 
tion of mCRBPII/CATl expression by mRARal was lower 
than by mRXRa, whereas in CV-1 cells only mRXRa, but 
not  mRARa1 induced mCRBPII/CATl expression (Table I, 
and  data  not shown). In HepG2 and CaCo-2  cells, there was 
only a weak stimulation by RA when RAR or RXR were 
cotransfected (Table I, and data not shown). No stimulation 
was observed under any conditions in the F9 and P19 em- 
bryonal carcinoma cells (EC), even though the RARP2 pro- 
moter was highly active in  these cells (Table I, and  data  not 
shown). This observation was particularly surprising in view 
of the previous results of Mangelsdorf et al. (45) who reported 
a markedly and specific activation of the  rat CRBPII pro- 
moter in F9 cells cotransfected with a RXR expression vector. 
To identify the elements responsible for RA-induced stim- 
ulation of mCRBPII  promoter activity, various deletion con- 
structs were made and cotransfected into Cos-1 cells with 
either mRARcvl or  mRXRa (Fig. 2B). mCRBPII/CAT2, 
which contains 760 bp upstream of the transcription  starting 
site, showed higher basal and RA-induced activities than 
mCRBPII/CATl. Deletion of the  RE1 sequence (mCRBPII/ 
CAT3) resulted in a slight increase in these activities. 
TABLE I 
Activity of CAT reporters for the  mCRBPII  promoter  (mCRBPII/CATl),  the  mRAR02promoter  (mRAR02jCAT) and the rRXRE/tk  promoter 
(rRXREjtk-CAT) in various cell types 
Cos-1,  CV-1, F9, HepG2, and CaCo-2 cells were transfected with 5 pg of CAT reporter constructs along with 0.5 pg of receptor expression 
vectors (or the parental vector pSG5) as indicated. The CAT  activity of the reporter cotransfected with pSG5 in absence of ligands is taken 
as one. The basal level activity of mCRBPII/CATl was 2-3-fold higher than  that of pBLCAT3+ in CaCo-2 and HepG2 ceils  (asterisks). 
Similarly, rRXRE/tk-CAT had -%fold higher basal level activity than pBLCAT8+ in CaCo-2 cells  (asterisk). The results correspond to the 
average (*15%) of several independent transfection experiments. 
Relative  CAT  activity 
Reporter Cell type pSG5 RARal  RXRa  RARal + RXRa rHNF-4 
- T-RA  9C-RA - T-RA 9C-RA - T-RA 9C-RA - T-RA  9C-RA - T-RA 9C-RA 
mCRBPIIjCAT1 COS-] 
c v - 1  
CaCo-2* 
HepG2* 
F9 
CaCo-2 
mRAR@2/CAT Cos-1 
HepG2 
F9 
CaCo-2* 
F9 
rRXRE/tk-CAT  os-1 
1 1.5 
1 1.5 
1 1.5 
1 1  
1 1  
1 12 
1 11 
1 34 
1 231 
1 1  
1 0.5 
1 4  
1.5 0.2 7.5 
1.5 1 1.5 
1.5 1 1.5 
1 0.7 1 
1 1  1 
10 0.5 131 
7 1 89 
27 0.7 48 
379 4 260 
1 0.7 2.5 
0.5 0.3 0.5 
5 0.5 5 
9 
1.5 
1.5 
1 
1 
146 
77 
46 
257 
5 
0.5 
9 
2.2 13 20 1.2 13.5 23 14.5 15 20 
2 9 1 4 1  6 11 44 33 31 
1 2 3 1.5 2 3 27 16 27 
0.8 2.1 2 1 1.2 1.6 10 9 7 
1 1 1 1  1 1 1  1 1 
1.5 37 40 1 105 122 2 99 94 
1 38 139 2 193 306 2 29 34 
2 46 48 1.8 42 33 0.9 43 35 
2 313 423 3 313 345 2 230 243 
1.3 59 183 1.7 23 97 4 4 5 
0.3 3 28 0.4 3 20 1 1 1 
1 24 16 1 35 40 8 13 15 
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FIG. 2. RA-inducibility of mouse CRBPII promoter activ- 
ity. A, 5 pg  of mRAR82ICAT and  mCRBPII/CATl (see "Materials 
and Methods") were transfected with 0.5  pg  of the indicated RAR or 
RXR expression vectors (or the  parental vector pSG5) into Cos-1 
cells. 1O"j  M T-RA or 9C-RA  were added 24 h  later, and cells were 
harvested after 24 h. Transfection efficiency was standardized by 
cotransfection of 2 pg  of the 8-galactosidase expression vector 
pCHIIO. B, plasmids (5 pg) carrying various lengths of the mCRBPII 
promoter in either pBLCAT3+ vector (rnCRBPZZ/CATZ-ZO) or 
pBLCAT8' vector (rnCRBPZZ/tk-CATG, -CAT2, and -CAT5) (see 
"Materials and Methods") were transfected into Cos-1 cells with the 
indicated RAR or RXR expression vector. Culture conditions and 
CAT assays were as in A. The length of mCRBPII gene 5"flanking 
fragments  is indicated in parentheses. The results (+15%) correspond 
to  the average of several independent  transfection experiments. 
mCRBPII/CAT4, which lacks part of the AG repeat (ouer- 
lined sequence in Fig. 1B) was as active as mCRBPII/CAT3. 
Deletion of the -447 to -525 sequence resulted in parallel 
reduction of constitutive and RA-induced activities 
(mCRBPII/CAT5). Note  that  this region contains  an  AP-1 
binding motif (Fig. 1B).  Further stepwise deletions to -268 
did not  alter constitutive nor RA-induced activities (Fig. 2B, 
mCRBPII/CATlO, and  data  not shown). 
The above results  indicated that a RARE(s) could be lo- 
cated between -268 and +60. Thus, a second series of reporter 
constructs were made, in which various lengths of 5"flanking 
mCRBPII sequences were cloned upstream of the herpes 
simplex virus thymidine kinase (tk) promoter (Fig. 2B, and 
data  not shown). mCRBPII/tk-CAT6, which contains RE1, 
RE2, and  RE3 sequences, was induced by RA when cotrans- 
fected with either  mRARa  or  mRXRa  in Cos-1 cells. Con- 
structs  containing only RE1  (but  not  RE2  nor  RE3)  and  the 
AP-1 binding site were not RA-responsive (mCRBPII/tk- 
CAT2, and data not shown). However, reporter constructs 
containing RE2 and RE3 responded to RA (mCRBPII/tk- 
CAT5, and  data  not shown). These results,  together  with the 
above deletion mutation analysis, indicated that some se- 
quences located between positions -40 and -268 were re- 
quired for RA inducibility. 
The possible function of the repeated motifs present in the 
putative response  elements  RE2 and  RE3 was investigated by 
generating mutations  in mCRBPII/CAT3 (Fig. 3A). 
mCRBPII/CAT3 mutl  to  mut4  contain  mutations in motifs 
1-4, respectively; mCRBPII/CAT3 mut5 to mut7 contain 
mutations  in motifs 1 and 2,Z and 3, and 3 and 4, respectively, 
whereas all four motifs are  mutated  in mCRBPII/CAT3 mut8. 
Mutation of motif 1 (mutl)  had no apparent effect (Fig. 3B). 
Mutation of either motif 2 (mut2) or motif 3 (mut3) impaired 
both  mRARal  and  mRXRa-mediated RA inducibility (note 
that  the A + C mutation abolished both  RXR homodimer 
and  RXR - RAR  heterodimer  binding to  the two RES, data not 
shown). Mutation of motif 4 also reduced RA inducibility, 
particularly in  the case of mRXRa.  Mutating motifs 1 and 2 
(mut5) had  the  same ffect as  mutating motif 2  alone (mut2), 
whereas mutating motifs  2 and 3 (mut6) resulted in a strong 
decrease in  mRXRa-mediated inducibility, and  in a complete 
loss of induction by mRARal. No induction was seen when 
motifs  3 and 4 (mut7) or all  4  motifs (mut8) were mutated. 
We conclude from these  results  that RE2, which is inactive 
on  its own (see mut7), can  cooperate  in RA inducibility with 
either motif 3 (see mutd), motif 4 (see mut3) or both motifs 
3 and 4 (compare mCRBPII/CAT3 and rnut5). In addition 
motif 1 appears  to be  dispensable (see mutl), a t  least when 
the  other motifs are  intact. We note also that  RE3 may be 
more efficient  with mRXRa  than with mRARa (see mut5), 
whereas the reverse situation may apply to  RE2 (see mut4). 
Binding of RARa and RXRa to mCRBPII RES in  Vitro- 
To investigate whether  the above differential effects of RE2 
and  RE3 in uiuo could be  correlated  with differences in binding 
of RAR and  RXRs  to  these  RES in vitro, binding retardation/ 
shift assays were carried out using  RE2 and  RE3 oligonucle- 
otide  probes (see Table I1 for their sequences) together  with 
either in vitro translated  hRARal (which is almost  identical 
to  mRARal, see Ref. 58) or  the antigen-tagged fusion protein, 
mRXRaER(F), which contains  the F region of the  human 
estrogen  receptor (hER) fused to  the C-terminal  amino acid 
of mRXRa (called mRXRaER(F)  in Ref. 17). The binding of 
RAR.  RXR heterodimers was also tested, as  they have been 
shown to  bind much more efficiently to RAREs than  either 
RAR or RXR homodimers (17) (see Introduction for addi- 
tional references). 
No detectable  binding of RARa alone was observed with 
either RE2 or RE3 in the absence or presence of RARa 
antibody (Fig. 4A, lanes 1 and 2).  Similarly RXRa alone did 
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FIG. 3. C h a r a c t e r i z a t i o n  of 
mCRBPII RAREs by site-directed 
mutagenesis. A ,  mutated sequences of 
mCRBPII RES in  mCRBPII/CAT3 
mutl  to mutt3 are indicated by asterisks 
and circles. B,  mutants (5 pg)  were trans- 
fected into Cos-1 cells along with 0.5 pg 
of RAR or RXR expression vectors, as 
indicated. Culture conditions and CAT 
assays were as in Fig. 2. 
A RE2 RE3 - 
B 
mCRBPIUCAT3mut3  mCRBPlUCAT3mut4  mCRBPlUCAT3muK 
mCRBPil/CAT3mut6  mCRBPIUCAT3mut7  mCRBPIVCAT3mutB 
not bind to either of the two probes (lane 3 ) ,  although a 
supershifted complex could be detected in the  RE3 case in 
the presence of RXR antibody (lane 4 ) .  In contrast, a complex 
was detected  in the presence of both  RARa and  RXRa (lane 
5), which could be supershifted by either  anti-RARa (lane 6) 
or anti-RXRa (lane 7) antibody. Thus,  RAR-RXR heterodi- 
mers  bind to both RE2 and  RE3 of the  CRBPII gene. Note 
that although  both the RE2 and  RE3 probes were labeled to 
approximately the same specific activity, the  intensity of the 
RAR.  RXR complexes were different (RE3 stronger than RE2 
complexes), and in  both cases lower than  that of the complex 
formed with the RARE of the RARP2 gene (PPRARE) (Fig. 
4A, and see below). Note also that, in contrast  to  the report 
of Zhang et al. (59), the addition of 9C-RA to  the reaction did 
not increase by more than 2-fold the formation of complexes 
between RXRa  and  the various RES  studied here and below 
(data  not shown). 
Binding of HNF-4 and ARP-1 to CRBPII RE2 and RE3 i n  
Vitro-That the mCRBPI1  promoter could not be induced by 
RA in HepG2 and CaCo-2 cells suggested to us that other 
factors may interact with the  CRBPII RAREs, thus prevent- 
ing RAR and  RXR binding. Comparison of CRBPII RE3 with 
the response elements of other members of the steroid hor- 
mone receptor superfamily revealed a similarity with an ele- 
ment  present in  the apolipoprotein CIII gene promoter, which 
binds the homodimers of orphan nuclear receptors HNF-4, 
ARP-1,  Ear2, and  Ear3 (apoCIII element in  Table 11) (53, 60, 
61). Similarly, CRBPII RE2 along with five nucleotides ex- 
tending in the 3'-direction (Fig. lB), exhibits some similarity 
with both the apoCIII element and a 20-fold weaker HNF-4 
binding site (HNF-4P) present in the transthyretin (TTR) 
gene (Table 11) (60). To investigate whether these trans- 
regulators could possibly bind to  the mCRBPII RES, binding 
assays were carried out with in vitro translated  rat  HNF-4 
(rHNF-4)  and human ARP-1  (hARP-1) antigen-tagged with 
the F region of hER  (hARP-lER(F)). We also investigated 
whether HNF-4 and ARP-1 could form heterodimers with 
each other, and with either RARs or RXRs. 
HNF-4 readily formed a specific complex with RE3 (Fig. 
4 A ,  lane 8). Addition of RARa (lane 9 )  or RXRa (lane I O )  
did not modify the formation of the  RE3.  HNF-4 complex, 
nor generated any additional complex, suggesting that RAR 
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TABLE I1 
Nucleotide sequence of response  eiement  probes  and summary of their binding to various receptors in vitro 
RG(G/T) TCA motifs are indicated by  arrows and degenerate nucleotides within motifs are indicated by dots. Numbers 1 to 6 over the 
arrows  in RE1 to 3 are the same as in Figure 1B. The location of the response elements in their respective promoters is indicated. The relative 
binding efficiency of each receptor homodimer or heterodimer to a given response element  has been simi-quantitatively scored from the 
results shown in  Fig. 4B (+ to 5+ scale in vertical columns).  Note  that the scores cannot be  compared horizontally for the binding efficiency 
of the different receptors to a given response element. 
GENE -
CRBPll 
CRBPll 
CRBPll 
CRBPll 
Synthetic 
rnRARp2 
hapoClll 
rnlTR 
RESPONSE  LEMENTS  R C P OR  BINDING  IN  VITRO 
..-.- - _). 2a 2 1 RAR:RXR HNF-4 ARP-1  ARP-1:RXR (RXR)P e 
RE2 6-GATCTTTGCAAAGTTCAACAGGTCTGTGW (-104- -1s) + - -  - - 
4 3 
2 + 2 
RE3 S - G A T C A ~ ~ G F ~ A ~ ~ A T A A G C C A ~  (61 m 62) ++  ++ ++++ ++ ++ - 
RE1 S-GATCCATTCTGCTG~'~'G~AC&A 
& 
S-CAGTTCATTTTCCJ'(-eWb 432) 
+ +++ + ? - 
rRXRE ~'-G=TCT=CA=TCAC 
." 
- 
AGGTCACAGGTCACAGTTCATTTTCC-3(SUm-Sm) 
++ + +++ ++ + 
DRlG S-TCGAGGGTAGGG~AGA-ACTCGJ *+ +++ +*+ +++ +c++ - 
and  RXRa do not heterodimerize with HNF-4. Like HNF-4, 
ARP-1 also formed a complex with RE3 (lanes 11 and 12). 
Addition of mRXRa (lane 14), but not mRARa (lane 13), 
along with ARP-1, resulted in an additional complex which 
could be supershifted with either  anti-ARP-1  ER(F)  or  anti- 
RXR antibodies (lane 15, and  data  not shown; note that  in 
all cases the binding of nuclear receptors tagged with the F 
region of the ER was identical to that of their wild-type 
counterparts). Thus ARP-1  can heterodimerize with RXRs, 
and the heterodimer can bind RE3. However, when both 
RARa and  RXRa were added along with ARP-1,  RAR.  RXR 
heterodimeric and  ARP-1 homodimeric complexes were pre- 
dominantly formed (lane 16), indicating that  RAR-RXR  het- 
erodimers are likely to be more stable than ARP-1.RXR 
heterodimers. The addition of both ARP-1 and HNF-4 to 
RE3  and other  elements used in  this tudy (see below) resulted 
in the formation of only two complexes (lanes 17 and 18), 
which migrated like those obtained with isolated ARP-1 and 
HNF-4, suggesting that  ARP-1  and HNF-4 do not heterodi- 
merize, in agreement with the recent results Mietus-Snyder 
et al. (62) obtained with the apoCIII element. In fact the two 
complexes observed here with both  ARP-1  and  HNF-4  and 
RE3  as well as  other elements migrated like those obtained 
with the apoCIII element (data  not shown). 
In contrast, no complex was formed between RE2 and 
HNF-4 in the absence (Fig. 4.4, lane 8) or in presence of 
RARa (lane 9) or RXRa (lane 10; the complex seen at  the 
bottom of the lane is nonspecific). Similarly, ARP-1  did  not 
bind to RE2 either on its own (lane 1 1 )  or together with 
RARa (lane 13) or RXRa (lane 14), and no specific complex 
could be detected when both  HNF-4  and  ARP-1 were added 
to RE2 (lane 17). However, weak RE2 .ARP-1 and RE2- 
HNF-4 supershifted complexes  were formed in  the presence 
of the corresponding antibodies (lane 12, and  data  not shown). 
Comparative Binding to Mouse CRBPII REI, Rat CRBPII 
RXRE, and a  Synthetic DRl Element in Vitro-As mentioned 
above, an element containing four directly repeated AG(G/ 
T)TCA motifs with 1-base pair  spacers was reported to be the 
RXR-specific response element of the rat CRBPII gene 
(rRXRE, see Ref.  45).  However, the corresponding region in 
the mouse CRBPII gene contains only two of these motifs 
(RE1 in Fig. lD), which do not appear to be required for 
either RAR or RXR-mediated induction of the mCRBPII 
promoter (see Fig. 2B). Therefore, we investigated the in  vitro 
binding properties of RE1  and compared them with those of 
rRXRE  and of a  synthetic element consisting of two directly 
repeated RGGTCA motifs separated by one bp (DRlG, see 
Table 11). Neither  rRXRE nor RE1 or DRlG bound to RARa 
alone (Fig. 4A, lune 1 ). Interestingly, a weak binding of 
mRXRa which  was greatly stabilized by the cognate antibody 
was observed with rRXRE, but not with RE1 (compare lanes 
3 and 4 of rRXRE and RE1 ), whereas a RXR-specific homo- 
dimeric complex which could be supershifted by the RXR 
antibody was readily detected with the  DRlG probe (lanes 3 
and 4 ) .  As it was the case for RE2 and RE3, a stronger RAR. 
RXR heterodimeric complex was observed in all three cases, 
which could be supershifted by antibodies directed against 
either RARa or RXRa (lanes 5-7). 
HNF-4 readily bound all  three probes, albeit with different 
efficiencies (see also below), and  this binding was not affected 
by the presence of either RARa or  RXRa (lanes 8-10). ARP- 
1 bound very efficiently to both rRXRE, RE1, and  DRlG 
(compare lanes 11 ). As in the case of RE3, an  ARP-1. RXRa 
heterodimeric complex was formed with all three probes, 
which could be supershifted by either  anti-ARP-1  or  anti- 
RXR antibody (lanes 14 and 15, and  data  not shown). How- 
ever, in the presence of RARa, RXRa,  and  ARP-l,  the major 
complexes formed corresponded to a RAR. RXR heterodi- 
meric complex and  a  ARP-1 homodimeric complex (lane 16). 
No HNF-4.  ARP-1 heterodimeric complexes could be detected 
(lanes 17). Note that,  in marked contrast with all of these 
results, a probe corresponding to  the RARE of the RARP2 
promoter (@BRARE)  was efficiently bound only by a  RAR. 
RXR heterodimer (Fig. U ) ,  although weak ARP-1 homodi- 
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FIG. 4. Binding in  vitro of RARa, RXRa, HNF-4, and ARP- 
1 to various response elements. A, 32P-5'-end-labeled oligonucle- 
otides containing mCRBPII RE1, RE2, or RE3, rCRBPII  rRXRE, 
P2RARE of the mRARP2 promoter or a  direct  repeat of RGGTCA 
separated by one nucleotide (see Table I1 for the nucleotide sequences) 
were incubated with in vitro transcribed-translated receptors, as 
indicated except in lanes 14 and 15 where mRXRa instead of 
mRXRaER(F) was added to the reactions. Where indicated, the 
respective antibodies were added subsequently. Incubation  mixtures 
were  resolved on 5% polyacrylamide gels and autoradiographed. Open 
arrowheads, closed arrowheads, and asterisks represent the retarded 
complexes that were supershifted by antibodies  against  RARa, 
meric and ARP-1 :RXR heterodimeric complexes could be 
observed at  higher  receptor  protein concentrations (lanes 1 1  
and 12,14 and 15, and  data  not shown). 
Relative Efficiency of Binding of RXR, HNF-4, ARP-1, 
RAR . RXR and ARP-1.  RXR in Vitro-The observation that 
the mCRBPII RES, rRXRE, and DRlG probes, although 
labeled to approximately the  same specific activity, yielded 
different amounts of receptor complexes (Fig. 4A) indicated 
that  the various  receptors have different  affinities for these 
RES. To  further characterize these differences, gel shift com- 
petition assays were carried  out,  using DRlG  as  the labeled 
probe, since it gave a specific complex with all of the receptors 
in direct binding assays (Fig. 4A). Competition was also 
performed with the RARPB gene RARE (see Table I1 for 
sequences and a  summary of the  results). 
The binding of RXR homodimer to  DRlG was most effi- 
ciently  inhibited by DRlG itself (lanes 17-19, Fig. 4B), 
whereas RE3 (lanes 14-16) and  rRXRE (lanes 5-7) were less 
efficient at  competing, although  still  much more efficient than 
RE1 (lanes 8-10). On the  other  hand P2RARE and RE2 did 
not compete, indicating that RXR homodimers bind very 
poorly, if at  all, to  these elements. The relative  affinities of 
HNF-4 for the various RES were DRlG > RE3 > rRXRE 2 
RE1 > RE2 2 02RARE to which HNF-4 did not  appear  to 
bind. ARP-1 homodimer, bound to  the various RES with the 
following decreasing order of efficiency: DRlG 2 RE3 > 
rRXRE 2 RE1 > RE2 > PPRARE. Thus,  HNF-4  appears  to 
have a greater affinity for RE3  than for RE1  and  rRXRE, 
whereas ARP-1 binds almost equally well to all three ele- 
ments. RXR.ARP-1 heterodimers were most efficiently com- 
peted by DRlG. Efficient  competition was also observed with 
rRXRE and RE3, whereas competition by RE1, and even 
more so by RE2  and PBRARE was weaker. RAR-RXR het- 
erodimers bound most strongly to PBRARE (DR5T).  Their 
relative binding efficiencies to  the  other RES were DRlG > 
rRXRE > RE3 > RE2 > RE1. 
Effect of HNF-4 and ARP-1 on Constitutive and RA-induced 
Activity of the CRBPII Promoter-The above receptor  binding 
results prompted  us  to investigate the effect of the expression 
of these receptors  on mCRBPII promoter  activity. Cos-1 cells 
were cotransfected  with either mCRBPII/CAT2 which con- 
tains RE1, RE2, and RE3, or mCRBPII/CAT3 which contains 
only RE2  and RE3. Since the individual mCRBPII  RES  and 
the  rRXRE exhibited  different  affinities for the various recep- 
tors in  vitro (see above),  tk-CAT  reporter constructs  contain- 
ing either one of these  RES were also used in  parallel  studies. 
For comparison, transfections were also performed with the 
mRARP2ICAT reporter (Fig. 5, and  data  not shown). 
mCRBPII/CAT3, which on its own has very little activity 
in Cos-1 cells, was stimulated -20-fold in a  ligand-independ- 
ent  manner when cotransfected  with HNF-4 (Fig. 5, compare 
lams 1 and 4, stippled bars). Addition of RA ligands had no 
mRXRa,  and ARP-1, respectively. RXR homodimers and ARP-1. 
RXR heterodimers are indicated by  closed arrows and open arrows, 
respectively. B, 32P-labeled DRlG (50 fmol) was incubated with rabbit 
reticulocyte lysates containing  either in vitro translated  RXRa,  HNF- 
4, ARP-1, RXRa,  and ARP-1, or RARa and  RXRa  as indicated (lane 
sponding to P2RARE (lanes 2-4), rRXRE (lanes 5-7),  RE1 (lanes 8- 
1 ). In lanes 2-19, non-radioactive competitor oligonucleotides corre- 
lo) ,  RE2 (lanes 11-13), RE3 (lanes 14-16), and  DRlG (lanes 17-19) 
were added. The quantity of non-radioactive competitors was 100 
fmol in lanes 2,5,8,11, 14, and  17 (2-fold excess over labeled probe), 
300 fmol in lanes 3, 6, 9, 12, 15, and 18 (6-fold excess); 1000  fmol in 
lanes 4, 7, 10, 13, 16, and  19 (20-fold excess). Equivalent  quantity of 
HNF-4  and ARP-1 were used in  competition reaction. The sequences 
of the competitor oligonucleotides are shown in  Table 11. 
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effect. When RARa, RXRa, and HNF-4 were transfected, 
some ligand-dependent increase was observed (Fig. 5,  compare 
lane 4 with 81, which disappeared when an excess of HNF-4 
expression vector was transfected (lane 9). Similarly, the 
ligand-dependent  activations  brought  about by either RARa 
or  RXRa (lanes 2 and 3 )  were lost upon cotransfection  with 
HNF-4 in excess (data  not shown and lune 9) .  Cotransfection 
of ARP-1 did not affect the ligand-independent  activation by 
HNF-4 (compare lane 4 with lane 7).  However, under  similar 
conditions, ARP-1 repressed the activation of the  mCRBPII 
promoter by either  RARa (data  not shown), RXRa (lane 6) ,  
or a combination of RARa  and  RXRa (lane 10). The ligand- 
independent activity of mCRBPII/CAT2, which contains 
RE1, was similar to  that of mCRBPII/CAT3 when cotrans- 
fected with HNF-4 alone (lane 4 ) .  Interestingly, under  the 
present  conditions, ARP-1 which did not repress the HNF-4- 
mediated ligand-independent  activation of mCRBPII/CAT3, 
repressed that of mCRBPII/CAT2 (compare lanes 7). How- 
ever, mCRBPII/CAT3 could be repressed to  the same extent 
as mCRBPII/CAT2, when a higher concentration of ARP-1 
was used (data not shown). Thus, RE1 may be an ARP-1- 
negative regulatory element of the mCRBPII  promoter  (see 
below). 
As in the case of the  natural mCRBPI1  promoter  constructs, 
RARa and  RXRa stimulated RE3/tk-CAT expression, albeit 
to a lesser extent (Fig. 5, lanes 2,3, and 5 ) .  Similarly, HNF- 
4 increased the ligand-independent  activity of this reporter 
by only 2-fold (Fig. 5, compare lanes 1 and 4 ) .  As with 
mCRBPII/CAT3, ARP-1 did not repress the stimulation gen- 
erated by HNF-4 (compare lanes 4 and 7 ) ,  whereas it reduced 
the ligand-dependent  activation observed with cotransfected 
RARa and  RXRa (compare lanes 3 with 6, and lunes 5 with 
10). However, in contrast to the case of mCRBPII/CAT3, 
HNF-4 failed to block the ligand-dependent activation by 
cotransfected  RARa and  RXRa (lanes 8 and 9) .  This failure 
of HNF-4, as well as its inability to strongly stimulate RE3/ 
tk-CAT (only %fold), suggests that  HNF-4 may  be less effi- 
cient at stimulating transcription from elements which con- 
tains only a single HNF-4 binding  site, since genes known to 
be activated by HNF-4 contain  either multiple HNF-4 binding 
sites (see Ref. 63) or binding sites for activators which can 
cooperate with HNF-4 (61, 62). In  this respect we note that 
the sequence 5’-AACAGCCCTCCCCACC-3’ at position -467 
to -482 of mCRBPI1 promoter (Fig. 1B) exhibits some ho- 
mology with the M element of the apoAII promoter (5’-  
CTCTCCCCCTCCCCCACC-3’) and  the H  element of 
the apoCIII promoter (5‘-CTTTGCCCCTCCCTCCACC-3’) 
which are required for efficient stimulation of these  promoters 
In  contrast  to RE3/tk-CAT, REZ/tk-CAT was  weakly in- 
duced by RARa (lane 2), but  not by RXRa (lane 3 ) ,  which is 
in agreement with the mCRBPII/CAT mutant results shown 
above in Fig. 3. The ligand-independent  activity of RE2/tk- 
CAT was weakly increased by HNF-4 expression (compare 
lanes 1 and 4 ) ,  and no repressing activity was seen with 
cotransfected  ARP-1 (lune 7) ,  in agreement with the in  vitro 
binding data. 
The RE1 element, which in the context of the natural 
mouse CRBPII promoter is not required for RA response, was 
also tested  in  Cos-1 cells for its ability to confer RA induci- 
bility to  the heterologous tk promoter. REl/tk-CAT expres- 
sion was induced 3-fold by cotransfection of either  RARa or 
RXRa (Fig. 5 ,  compare lanes 1, 2, and 31, and a 6-fold 
stimulation resulted from RARa  and  RXRa cotransfection 
(lane 5). A 2-fold ligand-independent  stimulation was gener- 
by HNF-4 (61). 
ated upon cotransfection with HNF-4 (lane 4 ) .  As with RE2/ 
tk-CAT and RE3/tk-CAT, HNF-4 did not repress ligand- 
dependent  activation by RARa and RXRa. However, in 
marked contrast  to RE2 and RE3/tk-CAT, ARP-1 behaved 
as a repressor in all cotransfection combinations (compare 
lanes 3, 4, and 5 with lanes 6, 7, and 10, respectively). The 
differential repressing effects of ARP-1 on  these various RES 
may reflect differences in receptor affinities for the RES, since 
the binding competition data suggest that  ARP-1  has similar 
affinities for RE1  and RE3, whereas RE1  has a lower affinity 
than  RE3 for both HNF-4  and RAR.  RXR heterodimers (Fig. 
4B).  These different bindings may explain why ARP-1 was 
more efficient at  preventing the HNF-4-mediated  activation 
of mCRBPII/CAT2, than of mCRBPII/CAT3 (see above). 
rRXRE/tk-CAT, which contains  the sequence 5’-AGGT- 
CACAGGTCA-3’ in  addition to  the  RE1 sequence (see Table 
II), was strongly  activated by RXRa in Cos-1 cells, but  not 
by RARa (Fig. 5, lanes 1, 2, and 3 ) .  The ligand-independent 
activity of this reporter was  4-fold enhanced in the presence 
of HNF-4 (lanes 1 and 4, and  Table I). When  cotransfected 
with either  RXRa  or RARa and  RXRa,  an excess of HNF-4 
resulted in  a  strong decrease in  9C-RA-dependent  activation 
(lane 9, and data not shown). In Cos-1 cells, the RXRa- 
mediated induction was reduced by 50% when RARa was 
present (compare lanes 3 and 5 ) .  However, RARa could not 
further repress this RXRa-mediated stimulation in Cos-1 
cells, even when cotransfected at  a 1O: l  ratio  (data  not shown). 
Interestingly, the magnitude of this RAR-related decrease 
was cell type-specific, as under  similar conditions (1:1 ratio) 
the stimulation of rRXRE/tk-CAT expression by RXRa was 
drastically decreased by cotransfection of RARa in CV-1 cells 
(data not shown), whereas no significant decrease was ob- 
served in CaCo-2 cells, and  an increase was actually observed 
in  F9 cells (Table I,  and  data  not shown). ARP-1  acted  as  a 
repressor of rRXRE/tk-CAT expression stimulated by RXRa 
(Fig. 5,  lanes 6 and lo),  but not by HNF-4 (see lane 7),  
inhibiting even more efficiently than in the case of mCRBPII/ 
CAT2 and  REl/tk-CAT. 
The ligand-independent  activity of mRARp2/CAT, whose 
RARE efficiently bound only RAR.RXR heterodimers in  
vitro, was not affected by HNF-4 (Fig. 5, compare lanes 1 and 
4 ) .  Surprisingly, the ligand-dependent activity was enhanced 
when mRARP2ICAT was transfected with either HNF-4 
alone or  in combination  with  RARa and  RXRa (lanes 4 ,  8, 
and 9). On the  other hand, ARP-1 had very little effect on 
the RA-induced expression of RARP2ICAT (lanes 6 and lo),  
whereas it slightly decreased the stimulation generated by 
HNF-4 in the presence of ligand (compare lanes 4 and 7). 
Since the PBRARE did  not bind HNF-4 in  vitro (see Fig. 4), 
these results suggest that the RARB2 gene 5”flanking se- 
quence contains  an  HNF-4  (and possibly also ARP-1) binding 
site which has  not yet been identified. 
To investigate whether all of the HNF-4 stimulation of 
mCRBPII/CAT3 was mediated through RE2 and RE3, or 
through  yet unidentified HNF-4 specific motifs, the effect of 
cotransfected HNF-4 on the activity of mCRBPII/CAT3, 
mCRBPII/CAT3mut5,  mCRBPII/CAT3mut7,  and 
mCRBPII/CAT3 mut8 was compared in Cos-1 cells. Mutation 
of RE2 (as in mCRBPII/CAT3mutii) did not specifically 
reduce the stimulation by HNF-4, whereas mutation of RE3, 
as in  mCRBPII/CAT3mut7, resulted in  a  dramatic decrease 
of this stimulation (from 23-fold to 3-fold this mutation 
completely abolished the binding of HNF-4 to RE3 in uitro, 
data  not shown).  Furthermore,  mCRBPII/CAT3  mut8 which 
is mutated  in  both RE2 and RE3 was not  activated by HNF- 
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FIG. 5. Effect  of  RARa,  RXRa, 
rHNF-4,  and  ARP- 1 on the  activity 
of the mCRBPII and RARB2 gene 
promoters and on trans-activation 
mediated by mCRBPI1 RE1, RE2, 
and  RE3,  and  rat  CRBPII  rRXRE. 
The various CAT reporter  constructs  are 
described in "Materials and Methods." 5 
pg of reporter plasmids were cotrans- 
fected into Cos-1 cells with the receptor 
expression vectors as indicated (0.5 pg 
each except in lane 9 where rHNF-4 was 
5 pg). Culture conditions were as in Fig. 
2. The sequences of RES and rRXRE 
cloned into the BarnHI site of 
pBLCATM vectors are shown in  Table 
11. The results (+15%) correspond to 
average of several independent  transfec- 
tion experiments. 
1 2 3 4 5 6 7 6 9 1 0   1 2 3 4 5 6 7 8 9 1 0  
mCRSPIWCAT3 rRXRE/tJtGAT 
RE3llk-CAT n 1 2 3 4 5 6 7 6 9 1 0  
20 
m R A R a -  + - - + - - + + + 
r H N F 4 -  - - + - - + + +' - m R X R a -  - + - + + - + + + 
10 hARP-1-  - - - - + + - - + 
0"u"""- 
1 2 3 4 5 6 7 6 9 1 0  
4 at all (data  not shown). Thus,  RE3  appears  to mediate most 
of the stimulation  generated by HNF-4.  Similar  results were 
obtained when transfections were performed in HepG2 and 
CaCo-2 cells in which overexpression of HNF-4 efficiently 
stimulated the  CRBPII promoter  activity (Table I, and  data 
not shown). 
DISCUSSION 
Several Putative  RA Response Elements  Are  Present  in the 
Mouse CRBPII  Promoter  Which Is Cell-specifically Activated 
by Cotransfected RAR and RXR-We have shown here that 
the mCRBPI1  promoter  responds to  T-RA  and 9C-RA when 
transfected into Cos-1, CV-1, and HeLa cells, along with 
vectors expressing either  RARa,  RXRa,  or both of them (Fig. 
2, Table I,  and  data  not shown). No significant response was 
observed in the F9 and P19 EC cell lines, in the hepatocarci- 
noma cell line (HepG2) and in the colon carcinoma cell line 
CaCo-2, even though the mCRBPI1 promoter exhibited a 
higher basal activity  in HepG2 and CaCo-2 cells, than in Cos- 
1, CV-1, F9, or P19 cells, and  the endogenous CRBPII gene 
was expressed in CaCo-2 cells.' Under  similar  conditions,  a 
well established RA-responsive promoter, the RARP2 pro- 
moter, was readily activated  in HepG2, CaCo-2, F9, or P19 
cells. Thus, the cell-specific activity of the mCRBPII pro- 
moter suggests the requirement for additional cell-specific 
activators which may cooperate with RAR and/or  RXR,  or 
alternatively the existence of cell and promoter-specific re- 
pressors which may prevent the action of RAR and RXR. 
Three putative RA response elements RE1, RE2, and  RE3 
have been identified in the  mCRBPII promoter (Figs. 2B, 3, 
and 4). All three RES correspond to two directly repeated 
motifs, separated by either 1-bp (RE1  and  RE3)  or 2-bp (RE2) 
spacers, which are  identical or related to  the consensus RG(G/ 
T)TCA motif found  in the response elements of all nuclear 
H. Nakshatri and P. Chambon, unpublished data. 
+ - + + +  
+ + +  
+ + " +  
- + + + -  
" 
receptors. All three RES could confer some RAR- and  RXR- 
mediated RA inducibility to  the  tk promoter (Fig. 5), although 
RE1  and RE2 were clearly less efficient than  RE3 (Fig. 5), 
and  RE3 appeared better stimulated by RXR  than by  RAR 
(Fig. 5, see also Fig.  3, mCRBPII/CAT3mutS versus 
mCRBPfflCAT3mut4). These transfection  results are in good 
agreement with the  data of DNA binding in  vitro, which  show 
that  RE3 was more efficient at binding RAR. RXR heterodi- 
mers, and also RXR homodimers, than either RE1 or RE2 
(Fig. 4, A and B) .  Note, however, that  RAR-RXR heterodi- 
mers bound much more efficiently than the corresponding 
homodimers, consistent with previous reports  (see  Introduc- 
tion).  Thus  RE3 may mediate activation by RXR homodimers 
only in cells which contain  a large excess of RXR over  RAR. 
Interestingly, the effects of RE1  and RE2 were different, 
when tested within the  mCRBPII promoter. If anything, RE1 
exerted  a  slight  inhibitory effect (Fig. 2B, compare mCRBPII/ 
CAT2 and mCRBPII/CAT3), whereas RE2, which had no 
effect on its own (Fig. 3, mCRBPII/CATmut7), clearly coop- 
erated with RE3 (compare mCRBPIIICAT3 and mut5 in Fig. 
3).  Thus  RE3 appears to be the only element which, within 
the  CRBPII promoter, responds on its own to RAR and RXR. 
The  Putative  Rat  CRBPII  RXR esponse Element (RXRE) 
Has No Functional Equivalent in the Mouse CRBPII Pro- 
moter-Mangelsdorf et al. (45) concluded from a  study of the 
rat  CRBPII promoter response to  RXR  and RAR, that  this 
promoter  responds selectively to  RXR through  a unique distal 
element called RXRE (Fig. lD),  whose deletion results  in  a 
total loss of RA response. Thus, although the proximal region 
of the  mCRBPII promoter which contains RE2 and  RE3 is 
almost fully conserved in the  rat  CRBPII promoter (Fig. ID), 
the role of these  elements was not observed by these  authors, 
most probably because they performed their experiments  in 
F9 cells, where the mouse CRBPII promoter is not activated 
by RAR and  RXR (Table I, see above). 
Interestingly, the putative rat  RXRE is not conserved in 
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the mCRBPII gene. In fact,  mCRBPII  RE1 corresponds to a 
truncated form of the  rat  RXRE from which the  first two 
AGGTCA motifs have been deleted (Fig. ID). Our results 
clearly show that  the properties of mCRBPII  RE1 and  rRXRE 
are different in terms of both DNA binding in  vitro, and RAR 
and RXR-mediated trans-activation  in  transfected cells. In 
contrast  to  REI,  and in agreement with the results of Man- 
gelsdorf et al. (45),  rRXRE very efficiently conferred  RXR 
(but  not RAR) responsiveness to a heterologous promoter in 
Cos-1 cells (Fig. 5, rRXRE/tk-CAT). Co-expression of RAR 
and RXR resulted in  a decrease of RXR-mediated rRXRE/ 
tk-CAT expression in Cos-1 cells. However, instead of the 
drastic inhibition which could be achieved in CV-1 cells ((45) 
and our data not shown), a - 50% inhibition plateau was 
reached irrespective of the excess of  RAR in Cos-1 cells (Fig. 
5, and  data  not shown). Interestingly, no significant inhibition 
was observed when RARa was cotransfected with RXRa  in 
CaCo-2 cells, and  a  stimulation was in  fact seen in F9 cells 
when RARa and  RXRa were cotransfected (Table I).  Fur- 
thermore the relative effects of T-RA and 9C-RA were mark- 
edly different in Cos-1, CaCo-2, and F9 cells (Table I, and 
data  not shown). Since rRXRE  binds more efficiently RAR. 
RXR heterodimers than  RXR homodimers (Fig. 4A), these 
differential cell type-related  inhibitions  and  activations may 
indicate that  the activation functions of the two partners of 
rRXRE-bound heterodimers could be mediated by cell-spe- 
cific factors. 
The high  degree of evolutionary conservation of the retinoid 
signaling pathway in general, and of the CRBPII  protein  and 
proximal promoter region in particular (Fig. l ) ,  together with 
the observation that RE1, the mouse counterpart of rRXRE, 
is not involved in mCRBPII promoter responsiveness to RA, 
raise the question as  to whether the non-conserved rCRBPII 
RXRE is in fact a physiologically relevant RXR response 
element (see below). 
The  Putative  CRBPII RA Response Elements, Particularly 
RE3,  Are also Binding Sites for  the  Orphan  Nuclear  Receptors 
HNF-4 and ARP-1-The pattern of expression of the  CRBPII 
gene  which is mainly confined to prenatal liver and intestine, 
and  adult  intestine  (46) resembles that of the apolipoprotein 
A, B  and  C genes (46, 62,  64-66). For example, the apolipo- 
protein CIII (apoCII1) gene is expressed predominantly in 
mammalian liver and intestine, and transfection studies in 
human hepatocarcinoma cells HepG2 and colon carcinoma 
cells CaCo-2 have shown that the activity of the apoCIII 
promoter is dependent on the binding of multiple factors to 
several cis-acting DNA elements (61,62,67,68). Interestingly, 
CRBPII RE3 is very similar to one of these elements (the 
apoCIII C3P site, see Table 11), which has been recently shown 
to bind several orphan members of the nuclear receptor su- 
perfamily, namely, HNF-4, ARP-1, and the ARP-1 closely 
related factors Ear2 and Ear3 (COUP-TF) (61, 62). The 
expression of HNF-4 is mostly restricted to liver, intestine, 
and kidney, while ARP-1, together with the closely related 
Ear3 (COUP-TF) is present in most tissues, and Ear2 is 
expressed mostly in liver (69). HNF-4  activates  transcription 
in reporter constructs  containing the C3P  site, whereas ARP- 
1,  Ear2  and  Ear3  (COUP-TF) repress HNF-4 activation by 
competing for the same C3P site (Refs. 61 and 62 and refer- 
ences therein). 
Our present results clearly show that both HNF-4 and 
ARP-1 efficiently interact with CRBPII RE3. In fact  HNF- 
4,  which binds much  more efficiently in  vitro to RE3 than  to 
RE1, RE2, and  rRXRE,  acts  through  RE3  as  a  strong acti- 
vator of the mCRBPII promoter (Figs. 4 and 5, and  data not 
shown). In all instances an excess of HNF-4 substantially 
decreased RA-dependent activation by RAR and/or RXR, 
supporting the in vitro data showing that these different 
receptors can bind to the same sites. ARP-1 binds most 
efficiently to RE3, but also to  RE1  and rRXRE, albeit with 
somewhat lower efficiency (Fig. 4). Accordingly, ARP-1 re- 
presses the activation of the mCRBPII promoter and of all 
individual CRBPII RES, which can be generated by co-expres- 
sion of either RAR and/or RXR (Fig. 5). ARP-1 was less 
efficient at repressing the HNF-4 induced activity, unless 
expressed at higher levels (Fig. 5  and  data  not shown), except 
when RE1 was present (mCRBPIIICAT2 in Fig. 5). Thus, 
RE1 may in fact correspond to a negative regulatory element 
of the mCRBPII promoter, mediating ARP-1 repression on 
either RAR/RXR or HNF-4 activation. Note that the rat 
RXRE, which also binds  ARP-1 very efficiently may  play a 
similar role in the rat CRBPII promoter. In addition, our 
results indicate that ARP-1 may also act negatively on RAR/ 
RXR  activation.  This may result from competition for binding 
to  the same element(s) (Fig. 4). Repression of RAR/RXR- 
mediated trans-activation by ARP-1 has been recently re- 
ported for other  promoters (70-72). 
As previously proposed by Ladias et al. (61) and Mietus- 
Snyder et al. (62) in the case of the apoCIII (in HepG2 and 
CaCo-2 cells), apoAII, and apoB promoters, the activity of 
the CRBPII promoter may primarily be modulated by the 
opposite effects of the activator HNF-4 and the repressor 
ARP-1 (or the related factors Ear2 and Ear3 (COUP-TF); 
note that substituting ARP-1 by COUP-TF yielded results 
similar to  those presented here for ARP-1  (data  not  shown)). 
This possibility is supported by the results of competition 
experiments which have shown that  the same gel shift com- 
plexes were formed between CaCo-2 or HepG2 cell extracts 
and either the CRBPII RE3 or the apoCIII C3P element.* 
These complexes that we could not supershift with anti-RAR 
or RXR antibodies have been previously shown in  the case  of 
C3P to correspond to  HNF-4  and ARP-1  (COUP-TF) com- 
plexes (62). In addition, ARP-1 may also repress RAR and 
RXR activity by forming inactive ARP-1.  RXR heterodimers, 
as suggested by the results of DNA binding gel shift experi- 
ments (Fig. 4). These suggestions are in agreement with the 
previous report of Kliewer et al. (73) who found that RXR 
and  COUP-TF  can  bind  as heterodimers to  rRXRE in  vitro. 
In  this respect, we note that ARP-1. RXRa heterodimers bind 
more efficiently to  RE3  and rRXRE than RXR homodimer 
(Fig. 4, and  data  not  shown), which is in keeping with the 
recent report of Widom et al. (74) who observed a similar 
preferential binding of ARP-1 .RXRa heterodimers on site A 
of the apolipoprotein AI (apoAI) promoter. In contrast, Tran 
et al. (72) found no evidence supporting COUP-TF/RXRa 
heterodimer binding to the rRXRE and the apoAI site A 
element. 
Finally, it is worth noting that neither  ARP-1 nor HNF-4 
bind efficiently to  the RARE of the RARP2 promoter 
(P2RARE in Fig. 4), even though this promoter could be 
activated by HNF-4,  and  this activation (but  not  the RAR. 
RXR  activation) could be repressed by ARP-1 (Fig. 5). These 
observations suggest that  the RARP2 promoter may contain 
a  HNF-4/ARP-1  (Ear3/COUP-TF) response element which 
has  not yet been identified. 
Is the Expression of CRBPII Gene Controlled by Retinoic 
Acids in Vivol-Although our present results and  those pre- 
viously reported by Mangelsdorf et al. (45) show that  the  rat 
and mouse CRBPII  promoters  can respond to overexpressed 
RXR  and RAR in cotransfection experiments, for these re- 
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sults to be  physiologically relevant, it  must be demonstrated 
that expression of the CRBPII gene can be stimulated by  RA 
treatment in uiuo. No data  are  presently available concerning 
a possible RA induction of CRBPII  transcripts or protein in 
prenatal liver or  intestine,  and in adult  intestine, which are 
known to express the  CRBPII protein and  transcripts (37,75, 
76).3 However, the enterocyte-like cell line CaCo-2 offers a 
possible alternative system to investigate the response of the 
CRBPII gene to  the retinoic acid signal, since CaCo-2 cells 
constitutively express CRBPII mRNA, and  at least the RARa, 
RARr,  and  RXRa genes are also constitutively expressed in 
these cells.3 Strikingly,  in CaCo-2 cells, the transfected 
mCRBPII promoter does not respond to  either endogenous 
or overexpressed receptors in  the presence of either  T-RA or 
9C-RA, whereas under the same conditions efficient stimu- 
lation of the RARP2 promoter is achieved in the same cells 
(Table  I). In contrast, under similar transfection conditions, 
the CRBPII promoter is activated by overexpressed HNF-4, 
and RA treatment does not result in any  further  stimulation 
(Table I). Therefore, it is likely that  the higher basal activity 
of the CRBPII promoter in HepG2 and CaCo-2 cells than in 
CV-1,  Cos-1,  F9, and P19 cells, is due to  the presence of HNF- 
4 which is known to be expressed in liver and  intestine (60) 
and also in CaCo-2 and HepG2 cells where it is present at a 
higher level than  ARP-1  and  Ear-3  (COUP-TF) (Ref. 62 and 
references therein). Note, incidentally, that  HNF-4 on its own 
is not sufficient to activate the  CRBPII promoter in F9 and 
P19 cells (Table I, and  data  not shown), even though ARP-1 
is not present in these cells,3 which suggests that EC cells 
lack a  factor(s) necessary to mediate HNF-4  activation. 
Thus, since CRBPII  RE3  and RE1 response elements have 
a much higher affinity for HNF-4  and  ARP-1  than for RAR. 
RXR heterodimers and RXR homodimers (Fig. 4, and  data 
not  shown), the transcription of the CRBPII gene could in 
fact be dependent upon the intracellular levels of HNF-4  and 
ARP-1, acting as positive and negative regulatory factors, 
respectively. Note in this respect that  CRBPII mRNA was 
not increased in the intestine of T-RA or 9C-RA treated 
mice.3  However, it  cannot be excluded that RA could stimulate 
the CRBPII promoter in cells where HNF-4  and  ARP-1  are 
absent or present at much lower levels than retinoic acid 
receptors, as it is the case in Cos-1 cells transfected with RAR 
and RXR expression vectors (see Fig. 2 and  Table I). 
In conclusion, the evidence available at  the present time 
strongly suggests that  the stimulation of the  CRBPII pro- 
moter generated by overexpression of RARs and RXR in 
transfected cells may reflect the promiscuous binding of these 
receptors to HNF-4/ARP-1 response elements. Further  stud- 
ies will establish whether HNF-4 is in  fact the major tran- 
scriptional  activator of the  CRBPII gene in vivo and whether 
this gene  could also be induced by  RA in tissues where HNF- 
4  and  ARP-1  are lacking or present in low amounts. 
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